The role of XPC: Implications in cancer and oxidative DNA damage

Mutation Research - Reviews in Mutation Research

Volumn 728, Issue 3, 2011, Pages 107-117

  Melis, Joost P M ^a,b   Luijten, Mirjam ^a   Mullenders, Leon H F ^b   Van Steeg, Harry ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Mutation; Nucleotide excision repair; Oxidative DNA damage; Xpc

Indexed keywords

OXYGEN; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

AGING; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; ENVIRONMENTAL FACTOR; EXCISION REPAIR; FIBROBLAST; GENOME; HOMEOSTASIS; HUMAN; KERATINOCYTE; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REDOX STRESS; REVIEW; XERODERMA PIGMENTOSUM;

AGING; ANIMALS; CELL CYCLE CHECKPOINTS; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; MICE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; XERODERMA PIGMENTOSUM;

MUS;

EID: 80053617155     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2011.07.001     Document Type: Review

References (139)

1. Lodish H., Berk A., Matsudaira P., Kaiser C.A., Krieger M., Scott M.P., Zipurksy S.L., Darnell J. Molecular Biology of the Cell 2004, WH Freeman, New York. 5th edition.
2. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993, 362:709-715.
3. Friedberg E.C. Out of the shadows and into the light: the emergence of DNA repair. Trends Biochem. Sci. 1995, 20:381.
4. Cadet J., Douki T., Gasparutto D., Ravanat J.L. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat. Res. 2003, 531:5-23.
5. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., Ellenberger T. DNA Repair and Mutagenesis 2006, ASM Press, Washington. 2nd edition.
6. Mullaart E., Lohman P.H., Berends F., Vijg J. DNA damage metabolism and aging. Mutat. Res. 1990, 237:189-210.
7. Bartek J., Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell Biol. 2007, 19:238-245.
8. Lo H.L., Nakajima S., Ma L., Walter B., Yasui A., Ethell D.W., Owen L.B. Differential biologic effects of CPD and 6-4PP UV-induced DNA damage on the induction of apoptosis and cell-cycle arrest. BMC Cancer 2005, 5:135.
9. de Boer J., Hoeijmakers J.H. Nucleotide excision repair and human syndromes. Carcinogenesis 2000, 21:453-460.
10. Guarente L.P., Partridge L., Wallace D.C. Molecular Biology of Aging 2008, Cold Spring Harbor Laboratory Press. 1st edition.
11. Garinis G.A., Jans J., van der Horst G.T. Photolyases: capturing the light to battle skin cancer. Future Oncol. 2006, 2:191-199.
12. Dip R., Camenisch U., Naegeli H. Mechanisms of DNA damage recognition and strand discrimination in human nucleotide excision repair. DNA Repair (Amst.) 2004, 3:1409-1423.
13. Yokoi M., Masutani C., Maekawa T., Sugasawa K., Ohkuma Y., Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J. Biol. Chem. 2000, 275:9870-9875.
14. Araujo S.J., Nigg E.A., Wood R.D. Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome. Mol. Cell Biol. 2001, 21:2281-2291.
15. Nishi R., Okuda Y., Watanabe E., Mori T., Iwai S., Masutani C., Sugasawa K., Hanaoka F. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein. Mol. Cell Biol. 2005, 25:5664-5674.
16. Araki M., Masutani C., Takemura M., Uchida A., Sugasawa K., Kondoh J., Ohkuma Y., Hanaoka F. Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J. Biol. Chem. 2001, 276:18665-18672.
17. Sugasawa K., Okamoto T., Shimizu Y., Masutani C., Iwai S., Hanaoka F. A multistep damage recognition mechanism for global genomic nucleotide excision repair. Genes Dev. 2001, 15:507-521.
18. Sugasawa K., Shimizu Y., Iwai S., Hanaoka F. A molecular mechanism for DNA damage recognition by the xeroderma pigmentosum group C protein complex. DNA Repair (Amst.) 2002, 1:95-107.
19. Min J.H., Pavletich N.P. Recognition of DNA damage by the Rad4 nucleotide excision repair protein. Nature 2007, 449:570-575.
20. Hoogstraten D., Bergink S., Ng J.M., Verbiest V.H., Luijsterburg M.S., Geverts B., Raams A., Dinant C., Hoeijmakers J.H., Vermeulen W., Houtsmuller A.B. Versatile DNA damage detection by the global genome nucleotide excision repair protein XPC. J. Cell Sci. 2008, 121:2850-2859.
21. Sugasawa K., Okuda Y., Saijo M., Nishi R., Matsuda N., Chu G., Mori T., Iwai S., Tanaka K., Tanaka K., Hanaoka F. UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell 2005, 121:387-400.
22. Fitch M.E., Nakajima S., Yasui A., Ford J.M. In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product. J. Biol. Chem. 2003, 278:46906-46910.
23. Tang J.Y., Hwang B.J., Ford J.M., Hanawalt P.C., Chu G. Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol. Cell 2000, 5:737-744.
24. Rapic-Otrin V., McLenigan M.P., Bisi D.C., Gonzalez M., Levine A.S. Sequential binding of UV DNA damage binding factor and degradation of the p48 subunit as early events after UV irradiation. Nucleic Acids Res. 2002, 30:2588-2598.
25. Ortolan T.G., Chen L., Tongaonkar P., Madura K. Rad23 stabilizes Rad4 from degradation by the Ub/proteasome pathway. Nucleic Acids Res. 2004, 32:6490-6500.
26. Ng J.M., Vermeulen W., van der Horst G.T., Bergink S., Sugasawa K., Vrieling H., Hoeijmakers J.H. A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein. Genes Dev. 2003, 17:1630-1645.
27. El Mahdy M.A., Zhu Q., Wang Q.E., Wani G., Praetorius-Ibba M., Wani A.A. Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC. J. Biol. Chem. 2006, 281:13404-13411.
28. Sugasawa K. XPC: its product and biological roles. Adv. Exp. Med. Biol. 2008, 637:47-56.
29. Tantin D., Kansal A., Carey M. Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes. Mol. Cell Biol. 1997, 17:6803-6814.
30. Tantin D. RNA polymerase II elongation complexes containing the Cockayne syndrome group B protein interact with a molecular complex containing the transcription factor IIH components xeroderma pigmentosum B and p62. J. Biol. Chem. 1998, 273:27794-27799.
31. Henning K.A., Li L., Iyer N., McDaniel L.D., Reagan M.S., Legerski R., Schultz R.A., Stefanini M., Lehmann A.R., Mayne L.V., Friedberg E.C. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell 1995, 82:555-564.
32. Nakatsu Y., Asahina H., Citterio E., Rademakers S., Vermeulen W., Kamiuchi S., Yeo J.P., Khaw M.C., Saijo M., Kodo N., Matsuda T., Hoeijmakers J.H., Tanaka K. XAB2, a novel tetratricopeptide repeat protein involved in transcription-coupled DNA repair and transcription. J. Biol. Chem. 2000, 275:34931-34937.
33. Groisman R., Polanowska J., Kuraoka I., Sawada J., Saijo M., Drapkin R., Kisselev A.F., Tanaka K., Nakatani Y. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 2003, 113:357-367.
34. Kamiuchi S., Saijo M., Citterio E., de Jager M., Hoeijmakers J.H., Tanaka K. Translocation of Cockayne syndrome group A protein to the nuclear matrix: possible relevance to transcription-coupled DNA repair. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:201-206.
35. Sunesen M., Stevnsner T., Brosh R.M., Dianov G.L., Bohr V.A. Global genome repair of 8-oxoG in hamster cells requires a functional CSB gene product. Oncogene 2002, 21:3571-3578.
36. Fousteri M., Mullenders L.H. Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 2008, 18:73-84.
37. Fousteri M., Vermeulen W., van Zeeland A.A., Mullenders L.H. Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol. Cell 2006, 23:471-482.
38. Giglia-Mari G., Coin F., Ranish J.A., Hoogstraten D., Theil A., Wijgers N., Jaspers N.G., Raams A., Argentini M., van der Spek P.J., Botta E., Stefanini M., Egly J.M., Aebersold R., Hoeijmakers J.H., Vermeulen W. A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nat. Genet. 2004, 36:714-719.
39. Goosen N. Scanning the DNA for damage by the nucleotide excision repair machinery. DNA Repair (Amst.) 2010, 9:593-596.
40. Oksenych V., Coin F. The long unwinding road: XPB and XPD helicases in damaged DNA opening. Cell Cycle 2010, 9:90-96.
41. Zotter A., Luijsterburg M.S., Warmerdam D.O., Ibrahim S., Nigg A., van Cappellen W.A., Hoeijmakers J.H., van Driel R., Vermeulen W., Houtsmuller A.B. Recruitment of the nucleotide excision repair endonuclease XPG to sites of UV-induced dna damage depends on functional TFIIH. Mol. Cell Biol. 2006, 26:8868-8879.
42. de Laat W.L., Appeldoorn E., Jaspers N.G., Hoeijmakers J.H. DNA structural elements required for ERCC1-XPF endonuclease activity. J. Biol. Chem. 1998, 273:7835-7842.
43. Hermanson-Miller I.L., Turchi J.J. Strand-specific binding of RPA and XPA to damaged duplex DNA. Biochemistry 2002, 41:2402-2408.
44. Andressoo J.O., Hoeijmakers J.H., Mitchell J.R. Nucleotide excision repair disorders and the balance between cancer and aging. Cell Cycle 2006, 5:2886-2888.
45. Coin F., Oksenych V., Mocquet V., Groh S., Blattner C., Egly J.M. Nucleotide excision repair driven by the dissociation of CAK from TFIIH. Mol. Cell 2008, 31:9-20.
46. Krasikova Y.S., Rechkunova N.I., Maltseva E.A., Petruseva I.O., Lavrik O.I. Localization of xeroderma pigmentosum group A protein and replication protein A on damaged DNA in nucleotide excision repair. Nucleic Acids Res. 2010, 38:8083-8094.
47. Park C.J., Choi B.S. The protein shuffle. Sequential interactions among components of the human nucleotide excision repair pathway. FEBS J. 2006, 273:1600-1608.
48. Hess M.T., Schwitter U., Petretta M., Giese B., Naegeli H. Bipartite substrate discrimination by human nucleotide excision repair. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:6664-6669.
49. Wakasugi M., Reardon J.T., Sancar A. The non-catalytic function of XPG protein during dual incision in human nucleotide excision repair. J. Biol. Chem. 1997, 272:16030-16034.
50. Staresincic L., Fagbemi A.F., Enzlin J.H., Gourdin A.M., Wijgers N., Dunand-Sauthier I., Giglia-Mari G., Clarkson S.G., Vermeulen W., Scharer O.D. Coordination of dual incision and repair synthesis in human nucleotide excision repair. EMBO J. 2009, 28:1111-1120.
51. Cleaver J.E., Lam E.T., Revet I. Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat. Rev. Genet. 2009, 10:756-768.
52. Bhutto A.M., Kirk S.H. Population distribution of xeroderma pigmentosum. Adv. Exp. Med. Biol. 2008, 637:138-143.
53. Kraemer K.H., Lee M.M., Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984, 5:511-514.
54. Kraemer K.H. Sunlight and skin cancer: another link revealed. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:11-14.
55. Cheo D.L., Ruven H.J., Meira L.B., Hammer R.E., Burns D.K., Tappe N.J., van Zeeland A.A., Mullenders L.H., Friedberg E.C. Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat. Res. 1997, 374:1-9.
56. Sands A.T., Abuin A., Sanchez A., Conti C.J., Bradley A. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 1995, 377:162-165.
57. Berg R.J., Ruven H.J., Sands A.T., de Gruijl F.R., Mullenders L.H. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. J. Invest. Dermatol. 1998, 110:405-409.
58. Cheo D.L., Meira L.B., Burns D.K., Reis A.M., Issac T., Friedberg E.C. Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors. Cancer Res. 2000, 60:1580-1584.
59. Cheo D.L., Meira L.B., Hammer R.E., Burns D.K., Doughty A.T., Friedberg E.C. Synergistic interactions between XPC and p53 mutations in double-mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer. Curr. Biol. 1996, 6:1691-1694.
60. Friedberg E.C., Cheo D.L., Meira L.B., Reis A.M. Cancer predisposition in mutant mice defective in the XPC DNA repair gene. Prog. Exp. Tumor Res. 1999, 35:37-52.
61. Friedberg E.C., Bond J.P., Burns D.K., Cheo D.L., Greenblatt M.S., Meira L.B., Nahari D., Reis A.M. Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat. Res. 2000, 459:99-108.
62. Cheo D.L., Burns D.K., Meira L.B., Houle J.F., Friedberg E.C. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice. Cancer Res. 1999, 59:771-775.
63. Hollander M.C., Philburn R.T., Patterson A.D., Velasco-Miguel S., Friedberg E.C., Linnoila R.I., Fornace A.J. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13200-13205.
64. Melis J.P., Wijnhoven S.W., Beems R.B., Roodbergen M., van den B.J., Moon H., Friedberg E., van der Horst G.T., Hoeijmakers J.H., Vijg J., van Steeg H. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res. 2008, 68:1347-1353.
65. Okamoto Y., Chou P.H., Kim S.Y., Suzuki N., Laxmi Y.R., Okamoto K., Liu X., Matsuda T., Shibutani S. Oxidative DNA damage in XPC-knockout and its wild mice treated with equine estrogen. Chem. Res. Toxicol. 2008, 21:1120-1124.
66. D'Errico M., Parlanti E., Teson M., de Jesus B.M., Degan P., Calcagnile A., Jaruga P., Bjoras M., Crescenzi M., Pedrini A.M., Egly J.M., Zambruno G., Stefanini M., Dizdaroglu M., Dogliotti E. New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J. 2006, 25:4305-4315.
67. Randerath K., Randerath E., Smith C.V., Chang J. Structural origins of bulky oxidative DNA adducts (type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem. Res. Toxicol. 1996, 9:247-254.
68. Wang Y. Bulky DNA lesions induced by reactive oxygen species. Chem. Res. Toxicol. 2008, 21:276-281.
69. Kuraoka I., Endou M., Yamaguchi Y., Wada T., Handa H., Tanaka K. Effects of endogenous DNA base lesions on transcription elongation by mammalian RNA polymerase II. Implications for transcription-coupled DNA repair and transcriptional mutagenesis. J. Biol. Chem. 2003, 278:7294-7299.
70. Kuraoka I., Suzuki K., Ito S., Hayashida M., Kwei J.S., Ikegami T., Handa H., Nakabeppu Y., Tanaka K. RNA polymerase II bypasses 8-oxoguanine in the presence of transcription elongation factor TFIIS. DNA Repair (Amst.) 2007, 6:841-851.
71. Kathe S.D., Shen G.P., Wallace S.S. Single-stranded breaks in DNA but not oxidative DNA base damages block transcriptional elongation by RNA polymerase II in HeLa cell nuclear extracts. J. Biol. Chem. 2004, 279:18511-18520.
72. Larsen E., Kwon K., Coin F., Egly J.M., Klungland A. Transcription activities at 8-oxoG lesions in DNA. DNA Repair (Amst.) 2004, 3:1457-1468.
73. Tornaletti S., Maeda L.S., Kolodner R.D., Hanawalt P.C. Effect of 8-oxoguanine on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II. DNA Repair (Amst.) 2004, 3:483-494.
74. Viswanathan A., Doetsch P.W. Effects of nonbulky DNA base damages on Escherichia coli RNA polymerase-mediated elongation and promoter clearance. J. Biol. Chem. 1998, 273:21276-21281.
75. Pastoriza G.M., Sarasin A. Transcription-coupled repair of 8-oxoguanine in human cells and its deficiency in some DNA repair diseases. Biochimie 2003, 85:1073-1082.
76. Pastoriza-Gallego M., Armier J., Sarasin A. Transcription through 8-oxoguanine in DNA repair-proficient and Csb(-)/Ogg1(-) DNA repair-deficient mouse embryonic fibroblasts is dependent upon promoter strength and sequence context. Mutagenesis 2007, 22:343-351.
77. Reardon J.T., Bessho T., Kung H.C., Bolton P.H., Sancar A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9463-9468.
78. Brooks P.J., Wise D.S., Berry D.A., Kosmoski J.V., Smerdon M.J., Somers R.L., Mackie H., Spoonde A.Y., Ackerman E.J., Coleman K., Tarone R.E., Robbins J.H. The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 2000, 275:22355-22362.
79. Brooks P.J. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 2007, 145:1407-1417.
80. Brooks P.J. The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair (Amst.) 2008, 7:1168-1179.
81. Bernardes de Jesus B.M., Bjoras M., Coin F., Egly J.M. Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC. Mol. Cell Biol. 2008, 28:7225-7235.
82. Shimizu Y., Iwai S., Hanaoka F., Sugasawa K. Xeroderma pigmentosum group C protein interacts physically and functionally with thymine DNA glycosylase. EMBO J. 2003, 22:164-173.
83. Miao F., Bouziane M., Dammann R., Masutani C., Hanaoka F., Pfeifer G., O'Connor T.R. 3-Methyladenine-DNA glycosylase (MPG protein) interacts with human RAD23 proteins. J. Biol. Chem. 2000, 275:28433-28438.
84. Kassam S.N., Rainbow A.J. Deficient base excision repair of oxidative DNA damage induced by methylene blue plus visible light in xeroderma pigmentosum group C fibroblasts. Biochem. Biophys. Res. Commun. 2007, 359:1004-1009.
85. Tuo J., Jaruga P., Rodriguez H., Bohr V.A., Dizdaroglu M. Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress. FASEB J. 2003, 17:668-674.
86. de Waard H., de Wit J., Gorgels T.G., van den A.G., Andressoo J.O., Vermeij M., van Steeg H., Hoeijmakers J.H., van der Horst G.T. Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair (Amst.) 2003, 2:13-25.
87. Tuo J., Chen C., Zeng X., Christiansen M., Bohr V.A. Functional crosstalk between hOgg1 and the helicase domain of Cockayne syndrome group B protein. DNA Repair (Amst.) 2002, 1:913-927.
88. Tuo J., Jaruga P., Rodriguez H., Dizdaroglu M., Bohr V.A. The cockayne syndrome group B gene product is involved in cellular repair of 8-hydroxyadenine in DNA. J. Biol. Chem. 2002, 277:30832-30837.
89. Thorslund T., von Kobbe C., Harrigan J.A., Indig F.E., Christiansen M., Stevnsner T., Bohr V.A. Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress. Mol. Cell Biol. 2005, 25:7625-7636.
90. Wong H.K., Muftuoglu M., Beck G., Imam S.Z., Bohr V.A., Wilson D.M. Cockayne syndrome B protein stimulates apurinic endonuclease 1 activity and protects against agents that introduce base excision repair intermediates. Nucleic Acids Res. 2007, 35:4103-4113.
91. Le Page F., Kwoh E.E., Avrutskaya A., Gentil A., Leadon S.A., Sarasin A., Cooper P.K. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell 2000, 101:159-171.
92. Dianov G., Bischoff C., Sunesen M., Bohr V.A. Repair of 8-oxoguanine in DNA is deficient in Cockayne syndrome group B cells. Nucleic Acids Res. 1999, 27:1365-1368.
93. Liu S.Y., Wen C.Y., Lee Y.J., Lee T.C. XPC silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage. Toxicol. Sci. 2010, 116:183-193.
94. Rezvani H.R., Kim A.L., Rossignol R., Ali N., Daly M., Mahfouf W., Bellance N., Taieb A., de Verneuil H., Mazurier F., Bickers D.R. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J. Clin. Invest. 2011, 121:195-211.
95. Rezvani H.R., Rossignol R., Ali N., Benard G., Tang X., Yang H.S., Jouary T., de Verneuil H., Taieb A., Kim A.L., Mazurier F. XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Biochim. Biophys. Acta 2011, 1807:609-619.
96. Langie S.A., Knaapen A.M., Houben J.M., van Kempen F.C., de Hoon J.P., Gottschalk R.W., Godschalk R.W., van Schooten F.J. The role of glutathione in the regulation of nucleotide excision repair during oxidative stress. Toxicol. Lett. 2007, 168:302-309.
97. Meira L.B., Reis A.M., Cheo D.L., Nahari D., Burns D.K., Friedberg E.C. Cancer predisposition in mutant mice defective in multiple genetic pathways: uncovering important genetic interactions. Mutat. Res. 2001, 477:51-58.
98. Kim S.T., Lim D.S., Canman C.E., Kastan M.B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 1999, 274:37538-37543.
99. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001, 15:2177-2196.
100. Wang G., Chuang L., Zhang X., Colton S., Dombkowski A., Reiners J., Diakiw A., Xu X.S. The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation. Nucleic Acids Res. 2004, 32:2231-2240.
101. Colton S.L., Xu X.S., Wang Y.A., Wang G. The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment. J. Biol. Chem. 2006, 281:27117-27125.
102. Ray A., Mir S.N., Wani G., Zhao Q., Battu A., Zhu Q., Wang Q.E., Wani A.A., Human SNF5/INI1 a component of the human SWI/SNF chromatin remodeling complex, promotes nucleotide excision repair by influencing ATM recruitment and downstream H2AX phosphorylation. Mol. Cell Biol. 2009, 29:6206-6219.
103. Auclair Y., Rouget R., Drobetsky E.A. ATR kinase as master regulator of nucleotide excision repair during S phase of the cell cycle. Cell Cycle 2009, 8:1865-1871.
104. Auclair Y., Rouget R., Affar e.B., Drobetsky E.A. ATR kinase is required for global genomic nucleotide excision repair exclusively during S phase in human cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17896-17901.
105. Wu X., Shell S.M., Liu Y., Zou Y. ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation. Oncogene 2007, 26:757-764.
106. Shell S.M., Li Z., Shkriabai N., Kvaratskhelia M., Brosey C., Serrano M.A., Chazin W.J., Musich P.R., Zou Y. Checkpoint kinase ATR promotes nucleotide excision repair of UV-induced DNA damage via physical interaction with xeroderma pigmentosum group A. J. Biol. Chem. 2009, 284:24213-24222.
107. Hwang B.J., Ford J.M., Hanawalt P.C., Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:424-428.
108. Adimoolam S., Ford J.M. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:12985-12990.
109. Amundson S.A., Patterson A., Do K.T., Fornace A.J. A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol. Ther. 2002, 1:145-149.
110. Wu Y.H., Wu T.C., Liao J.W., Yeh K.T., Chen C.Y., Lee H. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression. Cancer Res. 2010, 70:10422-10432.
111. Chen Z., Yang J., Wang G., Song B., Li J., Xu Z. Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res. 2007, 67:4578-4585.
112. Nahari D., McDaniel L.D., Task L.B., Daniel R.L., Velasco-Miguel S., Friedberg E.C. Mutations in the Trp53 gene of UV-irradiated Xpc mutant mice suggest a novel Xpc-dependent DNA repair process. DNA Repair (Amst.) 2004, 3:379-386.
113. Reis A.M., Cheo D.L., Meira L.B., Greenblatt M.S., Bond J.P., Nahari D., Friedberg E.C. Genotype-specific Trp53 mutational analysis in ultraviolet B radiation-induced skin cancers in Xpc and Xpc Trp53 mutant mice. Cancer Res. 2000, 60:1571-1579.
114. Xu X.S., Wang L., Abrams J., Wang G. Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer. J. Hematol. Oncol. 2011, 4:17.
115. Hu Z., Wang Y., Wang X., Liang G., Miao X., Xu Y., Tan W., Wei Q., Lin D., Shen H. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int. J. Cancer 2005, 115:478-483.
116. Lee G.Y., Jang J.S., Lee S.Y., Jeon H.S., Kim K.M., Choi J.E., Park J.M., Chae M.H., Lee W.K., Kam S., Kim I.S., Lee J.T., Jung T.H., Park J.Y. XPC polymorphisms and lung cancer risk. Int. J. Cancer 2005, 115:807-813.
117. Francisco G., Menezes P.R., Eluf-Neto J., Chammas R. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur. J. Hum. Genet. 2008, 16:724-734.
118. Qiu L., Wang Z., Shi X., Wang Z. Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur. J. Cancer 2008, 44:2241-2253.
119. de Verdier P.J., Sanyal S., Bermejo J.L., Steineck G., Hemminki K., Kumar R. Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients. Mutat. Res. 2010, 694:39-44.
120. Vineis P., Manuguerra M., Kavvoura F.K., Guarrera S., Allione A., Rosa F., Di Gregorio A., Polidoro S., Saletta F., Ioannidis J.P., Matullo G. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J. Natl. Cancer Inst. 2009, 101:24-36.
121. Shen H., Sturgis E.M., Khan S.G., Qiao Y., Shahlavi T., Eicher S.A., Xu Y., Wang X., Strom S.S., Spitz M.R., Kraemer K.H., Wei Q. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res. 2001, 61:3321-3325.
122. Marin M.S., Lopez-Cima M.F., Garcia-Castro L., Pascual T., Marron M.G., Tardon A. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol. Biomarkers Prev. 2004, 13:1788-1793.
123. Palli D., Polidoro S., D'Errico M., Saieva C., Guarrera S., Calcagnile A.S., Sera F., Allione A., Gemma S., Zanna I., Filomena A., Testai E., Caini S., Moretti R., Gomez-Miguel M.J., Nesi G., Luzzi I., Ottini L., Masala G., Matullo G., Dogliotti E. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis 2010, 25:569-575.
124. Gil J., Ramsey D., Stembalska A., Karpinski P., Pesz K.A., Laczmanska I., Leszczynski P., Grzebieniak Z., Sasiadek M.M. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol. Biol. Rep. 2011, [Epub ahead of print], PubMed PMID: 21559836.
125. Seril D.N., Liao J., Yang G.Y., Yang C.S. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003, 24:353-362.
126. Chang D., Wang F., Zhao Y.S., Pan H.Z. Evaluation of oxidative stress in colorectal cancer patients. Biomed. Environ. Sci. 2008, 21:286-289.
127. Soini Y., Haapasaari K.M., Vaarala M.H., Turpeenniemi-Hujanen T., Karja V., Karihtala P. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int. J. Clin. Exp. Pathol. 2011, 4:267-275.
128. Salim E.I., Morimura K., Menesi A., El Lity M., Fukushima S., Wanibuchi H. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int. J. Cancer 2008, 123:601-608.
129. Romanenko A., Morimura K., Wanibuchi H., Salim E.I., Kinoshita A., Kaneko M., Vozianov A., Fukushima S. Increased oxidative stress with gene alteration in urinary bladder urothelium after the Chernobyl accident. Int. J. Cancer 2000, 86:790-798.
130. Sung H.J., Ma W., Starost M.F., Lago C.U., Lim P.K., Sack M.N., Kang J.G., Wang P.Y., Hwang P.M. Ambient oxygen promotes tumorigenesis. PLoS ONE 2011, 6:e19785.
131. Yang J., Xu Z., Li J., Zhang R., Zhang G., Ji H., Song B., Chen Z. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome. J. Urol. 2010, 184:336-343.
132. Giglia G., Dumaz N., Drougard C., Avril M.F., Daya-Grosjean L., Sarasin A. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res. 1998, 58:4402-4409.
133. Castillo P., Bogliolo M., Surralles J. Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage. DNA Repair (Amst.) 2011, 10:518-525.
134. Wang S.C., Wu C.C., Wei Y.Y., Hong J.H., Chiang C.S. Inactivation of ataxia telangiectasia mutated gene can increase intracellular reactive oxygen species levels and alter radiation-induced cell death pathways in human glioma cells. Int. J. Radiat. Biol. 2011, 87:432-442.
135. Guo Z., Kozlov S., Lavin M.F., Person M.D., Paull T.T. ATM activation by oxidative stress. Science 2010, 330:517-521.
136. Helt C.E., Cliby W.A., Keng P.C., Bambara R.A., O'Reilly M.A. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage. J. Biol. Chem. 2005, 280:1186-1192.
137. Wu Y.H., Tsai Chang J.H., Cheng Y.W., Wu T.C., Chen C.Y., Lee H. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. Oncogene 2007, 26:4761-4773.
138. Nguyen T.A., Slattery S.D., Moon S.H., Darlington Y.F., Lu X., Donehower L.A. The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair. DNA Repair (Amst.) 2010, 9:813-823.
139. Zhou B., Wu H., Li W., Liu W., Luo D. Microarray analysis of microRNA expression in skin of Xpc(+/-) mice and wild-type mice. Ir. J. Med. Sci. 2010, [Epub ahead of print].